MOLDTKPACNSEMold-Tek Packaging Limited· Industrial ProductsHighPositive
Announced Mon, 9 Feb, 2026 · 15:46 IST

Q3 FY26: 9M sales up 12%, net profit up 18% to Rs 52 cr

Ebitda Margin ExpansionExceptional ItemResults View source PDFExplain this filing

MOLDTKPAC · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+9.8%Reaction day
₹541.85
prior close
₹545.50
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+1.0%+8.8% vs market
Packaging peers, median of 61sector+0.2%+9.6% vs sector

On the reaction day the stock moved 8.8 pts more than Nifty Microcap 250 and 9.6 pts more than its Packaging peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+3.1
10m
+3.6
15m
+3.8
30m
+5.0
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+9.8+1.0+8.8+0.2+9.6
Next day
+8.5+0.5+8.0+0.0+8.5
2d
+6.5-0.0+6.5+0.6+5.9
3d
+2.4-1.5+3.9-0.5+2.9
4d
+1.0-2.2+3.2-1.9+2.8
5d
+1.3-1.2+2.6-2.7+4.0
1w
+2.7-2.4+5.1-2.5+5.2
15d
+2.1-8.8+10.9-10.5+12.5
1m
-0.4-8.3+7.9-8.2+7.9
2m
+4.0-3.5+7.5-4.9+8.8
3m
+7.8+6.4+1.4-0.4+8.2
UpDownMarket · Nifty Microcap 250Sector · Packaging peers, median of 61Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Mold-Tek Packaging Q3 FY26: Sales rose 4% to Rs 198.67 cr, net profit up 5% to Rs 14.35 cr, EPS Rs 4.32. For 9M FY26: Sales up 12% to Rs 648.75 cr, EBITDA up 20% to Rs 125.55 cr with margin expansion, net profit up 18% to Rs 52.23 cr, EPS Rs 15.72. Pharma volumes surged 5x. Signed MoU with Vibe Generation UK for caps and closures targeting around 25-30 million USD over 5 years, and MoU with Swiggy for packaging. New Mahad unit being built for Grasim Industries.

Likely market impact

Strong double-digit 9M growth with margin expansion, pharma scale-up, and new MoUs signal positive momentum for the stock.